title: HLA mismatching as a strategy to reduce relapse after alternative donor transplantation.
abstract: Human leukocyte antigen (HLA) mismatches are targets of alloreactive T cells, mediators of graft-versus-leukemia (GvL) and graft-versus-host disease (GvHD) after alternative donor transplantation. Exploitation of HLA mismatching in order to reduce relapse is hampered by necessary interventions aimed at controlling GvHD on the one hand, and by the possibility of immune escape through selective loss of mismatched HLA in relapsing leukemia on the other. Retrospective studies reporting the impact of HLA mismatches on post-transplant relapse need to be interpreted with caution, due to many confounding factors, including disease and use of T-cell depletion, and to be constantly updated to the rapidly changing clinical protocols. Current evidence suggests similar relapse rates for 8/8, 7/8 HLA-matched unrelated, T-cell-replete haploidentical and umbilical cord blood transplantation; however, investigations of locus-specific effects are still scarce in the latter two settings. In unrelated transplantation, a specific role for mismatches at HLA-C and HLA-DPB1, and therein of permissive mismatches defined on the basis of T-cell alloreactivity and/or expression levels, in reducing relapse has been demonstrated in independent studies. This observation suggests new approaches to utilize HLA matching in unrelated donor searches, and the need for further research in the field.
authors.affiliation: Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. Electronic address: katharina.fleischhauer@uk-essen.de.
authors.forename: Katharina
authors.initials: K
authors.lastname: Fleischhauer
authors.affiliation: Department for Bone Marrow Transplantation, West-German Cancer Center, University Hospital Essen, Essen, Germany.
authors.forename: Dietrich W
authors.initials: DW
authors.lastname: Beelen
mesh_terms: D006086:Graft vs Host Disease / Q000276:immunology; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006649:Histocompatibility Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D012008:Recurrence; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D006649:Histocompatibility Antigens
keywords: Alloreactivity; Graft-versus-leukemia; HLA mismatch; Haploidentical HSCT; MUD HSCT; Umbilical cord blood HSCT